AKT1 and neoplasm: While both Pik3caH1047R expression and loss of function of PTEN enhance PIP3 lipid levels and lead to AKT activation, their effect on tumour development both in mouse models and in the clinic displays distinct latency, spectrum and sensitivity to chemotherapy11, 40, 41.